Reproductive ethics and the law

Reproductive ethics sits at the intersection of medical practice, legal regulation, and individual autonomy. For medical students, understanding this field requires moving beyond simple binary choices to appreciate the complex interplay of rights, duties, and societal values. The core concept often discussed is reproductive justice, which is defined not only as access to contraception but also as protection from structural vulnerability when contraception fails. This definition highlights that ethical care is not merely about providing a pill or a procedure, but about ensuring the patient is not left exposed to systemic harms when their chosen method fails. In many contexts, the law attempts to balance these individual rights against broader community standards or professional obligations, and this balance is rarely static. ^[1]

A significant area of study involves how people perceive the fundamental concepts of reproduction itself. Recent empirical studies, including those using experimental philosophy methods, have investigated whether reproduction is necessarily entailed by parenthood, or if genetic contribution is perceived as necessary or sufficient for these relationships. These philosophical inquiries help clarify the boundaries of legal personhood and parental rights. For instance, understanding whether 'x being y’s parent' entails that 'y is x’s child' is crucial for cases involving surrogacy, adoption, or assisted reproduction. While traditional ethics relied on abstract reasoning, modern approaches increasingly use interviews, focus groups, and surveys to investigate people’s actual opinions and experiences. This shift allows clinicians to understand the lived reality of patients, which often differs from theoretical legal frameworks. The methodology of experimental philosophy, however, remains distinct from the studies undertaken by empirical ethicists and qualitative researchers, offering a different lens to shed light on important issues in reproductive ethics.

The legal landscape varies significantly by jurisdiction, and this variation creates real-world consequences for patients and clinicians alike. In some regions, laws are designed to align with current practice and community attitudes, while in others, they remain restrictive or ambiguous. For example, in Saudi Arabia, policy permits abortion before 120 days when a woman’s mental health is at risk, but this provision remains largely inert in practice. The absence of standardised protocols for assessing psychological distress, no diagnostic thresholds to justify intervention, and no ethics review mechanisms tasked with adjudicating such cases mean that clinicians face institutional ambiguity and professional risk. This illustrates a key ethical challenge: when the law is clear on paper but vague in application, medical professionals must navigate a gap between legal permission and practical feasibility. Similarly, in Italy, there is growing awareness that the regulatory framework is ineffective in preventing fertility travels, where individuals seek procedures abroad that are restricted domestically. This highlights the need for an organic and comprehensive regulatory framework that strikes a fair balance for all parties involved, so as to ward off any ambiguity that might impinge upon the fundamental reproductive rights of all. ^[1]

The ethical analysis of these issues often requires a multi-disciplinary approach. Ethicists are increasingly undertaking empirical work, overlapping with qualitative research and experimental philosophy. For medical students, the takeaway is that ethical competence involves understanding both the hard law and the soft social norms that influence patient decision-making. It also involves recognizing that legal reforms, such as those in Victoria, Australia, aim to remove abortion from criminal statutes and clearly specify grounds for termination, thereby reducing ambiguity for practitioners. In Victoria, the Abortion Law Reform Act 2008 made abortion legally permissible for a woman giving free and informed consent at any stage of gestation and for any reason, with the proviso that after 24 weeks, two doctors must agree that "it is appropriate in all the circumstances". This dual threshold—free consent at any stage, but a two-doctor agreement after 24 weeks—demonstrates how law attempts to balance autonomy with fetal viability concerns. ^[6]

Consent is the cornerstone of ethical reproductive care. In the context of contraception and sterilisation, informed consent requires that patients understand the nature, risks, and alternatives of the procedure. However, the legal and ethical frameworks governing this consent can be complex, particularly when conscientious objection (CO) by healthcare providers is involved. A prominent example is the Abortion Law Reform Act in Victoria, Australia, passed in 2008, which aimed to bring the law relating to termination of pregnancy into line with current practice and community attitudes. One of the threefold purposes of this Act was to outline the obligations of registered health practitioners with a conscientious objection to abortion. Specifically, Section 8 of the Act requires doctors with a conscientious objection to abortion to refer women to another provider. This legal requirement is designed to ensure that a patient’s right to access legal services is not hindered by a provider’s personal moral or religious beliefs. ^[6]

The implementation of such laws is not without challenges. Studies of abortion experts in Victoria have reported views on the operation of Section 8, noting that while the law provides clarity, negative consequences can still arise. All nineteen participants in one such study were able to relate specific stories about doctors subverting, misusing, or directly contravening the law. These negative consequences arose either from Section 8 not being followed, or being followed inappropriately. For example, a doctor might refuse to refer a patient and instead delay the process, or refer to a service that is not actually accessible. This demonstrates that even clear legal mandates can be undermined by individual practice, and that patients may face barriers despite legal protections. ^[6]

Participants in the Victorian study were divided as to how important it was that the responsibilities of conscientious objectors be enshrined in law. Some felt the underlying premise was similar to the principles outlined in the Australian Medical Association’s Code of Ethics and the Medical Board of Australia’s 'Good medical practice: a code of conduct for doctors in Australia', and therefore wondered why Section 8 had been positioned in law rather than specifically embedded within professional practice guidelines. However, others emphasised the significance of having it in law: "It makes an enormous difference to have it in law - I think this is a big deal, to have in law that doctors are legally bound to refer you on to a service that will provide the service. It’s not necessarily going to happen just like that, but to have that clear is really good". This quote captures the tension between professional self-regulation and statutory enforcement. ^[6]

For contraception and sterilisation specifically, consent must be free and informed, meaning the patient understands the permanence of sterilisation, the alternatives (including long-acting reversible contraception), and the risks of failure. The concept of reproductive justice applies here too: access to contraception is not sufficient; patients must also be protected from structural vulnerability when contraception fails. A cross-sectional study in Jeddah identified that even among women with high awareness of contraception, unplanned pregnancies were not uncommon—and when they occurred, they triggered intense psychological distress, especially in those with limited support systems. This finding underscores that consent for contraception is not merely a technical checklist but a process embedded in social context. Clinicians should assess not only knowledge but also support systems, as unplanned pregnancy distress is amplified in vulnerable populations.

Special populations require additional consideration. For minors seeking contraception or sterilisation, the legal framework varies; in many jurisdictions, mature minors may consent to contraception, but sterilisation often requires additional safeguards. In low-resource settings, access to contraception may be limited, and the ethical obligation to provide reproductive justice becomes more pressing. For older adults, sterilisation may be requested for medical reasons, and consent must be evaluated in light of cognitive capacity. In all cases, the principle of free and informed consent remains paramount, and clinicians must be aware of both the legal requirements and the ethical imperatives. The Victorian example shows that law can provide clarity, but professional vigilance is needed to ensure that conscientious objection does not become a barrier to care.

Conscientious objection (CO) in abortion care is the right of a health practitioner to refuse to participate in abortion procedures or related advice on grounds of personal moral or religious belief. The law must balance this right against the patient’s right to access lawful abortion care. In Victoria, Australia, this balance is struck by Section 8 of the Abortion Law Reform Act, which sets out a clear two-step duty for any practitioner who holds a CO.

Under Section 8, the obligation applies to any health practitioner asked to advise about abortion, or to perform, direct, authorise or supervise an abortion. Non-compliance can lead to charges of professional misconduct by the practitioner’s registering authority. Importantly, the referral duty is narrower than many assume: a general practitioner need only refer to another GP without a CO, not to an abortion service. This distinction matters because anti-abortion groups have used the media to suggest that Section 8 forces objectors to refer women directly to abortion providers—a perception that is legally inaccurate. ^[6]

Globally, the legal position on CO varies widely. At one end, countries including Sweden, Finland, Bulgaria, Czech Republic and Iceland do not permit CO. In Sweden, for example, the abortion act is rights-based, there is a policy ban on CO, abortion care is a mandatory part of medical training, and provision in public hospitals is expected—so those who object cannot become obstetricians/gynaecologists or midwives. Legal challenges to this ban have so far failed. ^[6]

In practice, however, the Victorian law has not always worked smoothly. Qualitative research with experts in abortion provision found that while most supported Section 8 as a mechanism to protect women’s access, all could describe negative experiences. These arose when doctors directly contravened the law by not referring, attempted to make women feel guilty, delayed access, or claimed an objection for reasons other than conscience. Misuse was also reported among Government telephone staff, pharmacists, institutions and political groups. The most common harm occurred in face-to-face consultations, where improper CO use increased guilt and discomfort, delayed access, and in rare cases prevented access altogether. ^[6]

Experts also noted that institutional opting out is legally questionable—as one participant put it, “I have a really strong objection to institutional opting out because there’s nothing in the law about that and that’s wrong”. Some called for clearer guidelines, similar to those proposed in South Africa, to disentangle genuine CO from general resistance to abortion provision. Such guidelines could reduce disingenuous claims and counter misinformation about Section 8. ^[6]

For medical students, the key takeaway is practical: if you hold a CO, you must declare it and refer on—but you must not obstruct, delay, or judge. If you do not hold a CO, you have a duty to provide or facilitate care. The law protects conscience, but it protects women’s access first.

Since the 1970s, with the development of bioethics as a distinct discipline and the advent of in vitro fertilisation (IVF), questions about ethics and reproductive technologies have proliferated. As new biomedical possibilities emerge, terms such as ‘mother’, ‘biological parent’ and ‘reproduction’ have come under scrutiny; concepts previously regarded as biologically given are now increasingly recognised as negotiable, underdetermined, or partly or wholly socially constructed. ^[2]

Medically-assisted reproductive methods have given rise to profound social and ethical quandaries that affect the very nature of family relationships, as well as the inherent value of the human embryo. The surrogate embryo transfer technique has further complicated the issue of parenting, making it possible to distinguish among genetic mother, gestational mother and intended mother. In Italy, surrogacy—often termed by its detractors “uterus for rental”—is subject to law No. 40 of 19 February 2004: “Regulations on medically assisted procreation”. While some states ban surrogacy contracts or make them null and void, others allow such agreements to be enforced. ^[4]

Philosophical accounts of parenthood differ markedly. Some privilege biological connections; others focus on the intentions of prospective parents; still others take the causal processes involved in conception to be a key component. A Lockean approach views parenthood as a status acquired through one’s activities—especially caring activities—in relation to a child. On biological accounts, parenthood may be construed as a fixed genetic relationship, necessarily connected with reproduction. ^[2]

Experimental philosophy, especially the flavour using vignettes, has more in common with conceptual engineering than with empirical ethics and qualitative research. The vital thing is to be concise in pinpointing the concepts to be analysed, cautious in interpreting data, and to avoid leaping too quickly from findings to normative conclusions. This method is fruitful for analysing concepts in reproductive ethics, which are often fraught with vagueness and uncertainties. ^[2]

Reproductive problems and infertility have always exerted a strong psychological pressure. Psychological distress, along with religious and procedural factors, significantly shapes maternal decision-making—even in cases where abortion is legally permitted, such as foetal anomaly. Mental health remains insufficiently addressed—whether as a reason for care or a factor in women’s ability to access and navigate reproductive decisions. ^{[4] [1]}

Genetic testing in the reproductive setting raises distinctive ethical questions because results rarely concern only the tested individual. A fetal or parental genetic result can alter reproductive decisions, guide prenatal diagnosis, and carry implications for parents and more remote family members. The ethical duty to communicate results accurately therefore extends beyond the laboratory to the clinic and the family. ^[3]

Before any genetic test, the purpose must be clearly identified—for example, confirmation of a diagnosis, differential diagnosis, carrier testing, presymptomatic testing, or prenatal testing. This clarity is not merely administrative; it determines what information the patient can reasonably expect and what decisions the result can inform. The referring physician must provide relevant clinical, laboratory, imaging, genealogic, and genetic data, including ethnicity where relevant, so the laboratory can select appropriate methods and calculate residual risks. Without this, interpretation may be incomplete or misleading. ^[3]

Genetic testing should not be offered as a bare laboratory service. The test report must remind the referring physician that genetic tests should be accompanied by genetic counselling. For prenatal diagnosis, presymptomatic testing, or results with major implications for other family members, the report should state that the result and its implications should be transmitted only in a specialised genetic consultation. This protects against the harm of unsupported disclosure of life-changing information. ^[3]

Invasive testing is not ethically neutral. Because of the increased risk of fetal loss, invasive prenatal diagnostic testing is not recommended for all pregnant women aged over 35 years. This challenges the older assumption that maternal age alone justifies invasive testing. Instead, the decision should weigh the risk of the procedure against the likelihood and severity of a fetal abnormality. ^[5]

Anti-immunoglobulin should be administered within 72 hours after invasive diagnostic testing to prevent sensitisation in Rh-negative women. Antibiotics are not recommended before or after the procedure. Chromosomal microarray is not recommended for all pregnant women undergoing invasive testing, reflecting concern about over-testing and uncertain findings. In twin pregnancies, the risk of fetal loss from invasive testing is higher than in singletons, and in monochorionic twins with consistent growth and structure, testing may be performed on one fetus alone. ^[5]

Surrogacy is an arrangement in which a woman (the surrogate) carries and delivers a child for another person or couple (the intended parents). It is one of the oldest solutions to infertility, yet it remains one of the most ethically and legally contested areas of reproductive medicine. The American College of Obstetricians and Gynecologists (ACOG) published its first statement on the topic in 1983, and since then the practice has become more common. However, the legal landscape worldwide is fragmented, with some countries embracing surrogacy, others banning it outright, and many occupying a grey zone of partial regulation. ^[4]

There are two main types of surrogacy. In traditional surrogacy, the surrogate’s own egg is used, making her the genetic mother. In gestational surrogacy, the embryo is created using the intended mother’s egg (or a donor egg) and the intended father’s sperm (or donor sperm), so the surrogate has no genetic link to the child. This distinction matters ethically because it affects the surrogate’s biological connection to the child and, consequently, the emotional and legal complexities involved.

The legal position varies dramatically across the world. In the United States, surrogacy is regulated at the state level, and commercial surrogacy is legal in most states, with varying degrees of restrictions. The sole exceptions are Louisiana, Nebraska and Michigan, where commercial surrogacy is not permitted. In Australia, surrogacy is regulated at the territorial level, and altruistic surrogacy is legal in all states and territories except one. This patchwork of laws creates significant practical challenges for intended parents, who may travel across state or national borders to access surrogacy services. ^[4]

In Europe, the picture is similarly diverse. Greece allows surrogacy, but only with permission from a court of law, which must certify that the person or couple requesting it cannot otherwise have children. This judicial oversight is designed to prevent surrogacy from being used as a convenience rather than a medical necessity. In Italy, surrogacy is effectively unavailable, and even second-parent adoption for same-sex couples is not legally recognized, reflecting the contentious nature of assisted reproduction in that country. ^[4]

Beyond Europe, the situation is equally varied. India banned commercial surrogacy in 2018, although altruistic surrogacy remains legal for residents. Russia stands out as a major exception, allowing commercial surrogacy, which has made it a destination for international intended parents. Ukraine has similarly become a commercial surrogacy “promised land,” particularly as other countries have banned or severely restricted the practice. This movement of intended parents and surrogates across borders—often called “reproductive tourism”—raises serious ethical concerns about exploitation and the regulation of cross-border arrangements. ^[4]

The ethical arguments for and against surrogacy are deeply polarizing. Proponents argue that surrogacy supports reproductive autonomy and allows individuals who cannot carry a pregnancy to have genetically related children. Opponents raise concerns about the commodification of women’s bodies, particularly in commercial arrangements, and the potential for exploitation of vulnerable women. These concerns are especially acute in cross-border surrogacy, where surrogates in lower-income countries may be paid far less than their counterparts in wealthier nations, and where legal protections may be weaker.

When medical students encounter surrogacy, several common pitfalls arise in their understanding and reasoning. These pitfalls can lead to flawed ethical analysis or poor clinical judgment.

Pitfall 1: Assuming surrogacy is a modern invention. Surrogacy is often perceived as a product of modern reproductive technology, but it has been around for a long time. The ethical questions it raises are not new, even if the technological options have expanded. Recognising this historical context helps students appreciate that surrogacy is not a novelty but an enduring response to infertility.

Pitfall 2: Conflating legal and ethical permissibility. Just because surrogacy is legal in a jurisdiction does not mean it is ethically unproblematic, and vice versa. For example, commercial surrogacy is legal in most US states, yet many ethicists argue that it exploits women. Conversely, altruistic surrogacy may be legal but still raise concerns about coercion within families. Students should separate legal analysis from ethical reasoning.

Pitfall 3: Overlooking the surrogate’s perspective. Students often focus on the intended parents’ desire for a child and neglect the surrogate’s experience. The surrogate is not merely a vessel; she is a woman with her own interests, vulnerabilities and rights. This is particularly important in commercial arrangements, where financial incentives may cloud judgment. The risk of exploitation is a central ethical concern, especially for vulnerable women.

Pitfall 4: Ignoring the child’s interests. The child born through surrogacy is often forgotten in ethical debates. Questions about the child’s right to know their genetic origins, their relationship with the surrogate, and the psychological impact of being born through surrogacy are all relevant. Students should consider the child’s welfare as a key stakeholder.

Pitfall 5: Assuming surrogacy is equally accessible to all. Surrogacy is not available to everyone. In countries such as India, Russia, Nigeria and Thailand, gay couples or singles cannot resort to surrogacy even where it is legal for heterosexual couples. This raises issues of discrimination and unequal access to reproductive services.

Pitfall 6: Failing to consider cross-border implications. The ease with which intended parents can travel to another country for surrogacy creates legal and ethical grey zones. Agencies can exploit loopholes by moving eggs, sperm, embryos, surrogates and intended parents to countries where commercial surrogacy is still legal. This can lead to underground, unregulated agreements that harm vulnerable women. Students should be aware that surrogacy is rarely a purely domestic issue.

Pitfall 7: Misunderstanding the genetic contribution. People’s intuitions about parenthood in surrogacy are not always consistent. Research shows that opinions on who has reproduced, who is a parent, and who has a child differ depending on the genetic contribution. For example, in a scenario where a younger brother donates sperm, people were more inclined to say the brother is a parent than to say the resulting child is his child (p<0.001). This asymmetry suggests that people’s concepts o ^[2]

Surrogacy is used in practice across a range of clinical and social scenarios. Understanding where and how it is applied helps medical students appreciate its real-world relevance.

Clinical indications. Surrogacy is typically considered when a woman cannot carry a pregnancy to term. This may be due to congenital absence of the uterus (e.g., Mayer-Rokitansky-Küster-Hauser syndrome), surgical removal of the uterus (hysterectomy), severe uterine abnormalities, or medical conditions that make pregnancy dangerous (e.g., severe cardiac or renal disease). In Greece, for example, court permission is required, certifying that the person or couple cannot otherwise have children. This criterion ensures that surrogacy is reserved for medical necessity rather than convenience.

Same-sex couples and single men. Surrogacy is a common route to parenthood for gay male couples and single men, who cannot carry a pregnancy themselves. However, access is not universal. In some countries, surrogacy is legal for heterosexuals but not for gay couples or singles—for example, in India, Russia, Nigeria and Thailand. This disparity creates significant barriers and often drives intended parents to seek surrogacy abroad.

Cross-border surrogacy. In practice, many intended parents travel to countries where surrogacy is legal and accessible. Ukraine has become a major destination for commercial surrogacy, particularly as other countries have banned or restricted the practice. This movement of people and embryos across borders is largely unregulated, raising concerns about the protection of surrogates and the legal status of the resulting children.

Regulatory frameworks in practice. The practical application of surrogacy depends heavily on the regulatory environment. In the United States, the state-level variation means that intended parents may choose a state based on its laws. For example, commercial surrogacy is legal in most states, but not in Louisiana, Nebraska and Michigan. In Australia, altruistic surrogacy is legal in all states and territories except one. This means that even within a single country, the practical availability of surrogacy can differ significantly.

Altruistic versus commercial surrogacy. In practice, most countries that allow surrogacy permit altruistic arrangements, while commercial surrogacy is the exception, with Russia being a notable example. Altruistic surrogacy typically involves a family member or friend who carries the child without payment beyond reasonable expenses. Commercial surrogacy involves payment for the service itself, which raises additional ethical concerns about exploitation. The distinction is crucial in practice because it affects the legal enforceability of the arrangement and the surrogate’s motivations.

The role of surrogacy agencies. In practice, surrogacy agencies play a significant role in facilitating arrangements. They match intended parents with surrogates, coordinate legal and medical processes, and manage the financial aspects. However, agencies can also exploit loopholes in the law, moving eggs, sperm, embryos, surrogates and intended parents to countries where commercial surrogacy is still legal. This can lead to unregulated and unsupervised agreements that may harm vulnerable women. Medical students should be aware of the potential for exploitation in agency-mediated arrangements.

Ethical practice in clinical settings. When surrogacy is used in practice, clinicians have a duty to ensure that all parties give informed consent. This includes explaining the medical risks of pregnancy to the surrogate, the success rates of IVF, and the legal implications of the arrangement. Clinicians should also be alert to signs of coercion or exploitation, particularly in commercial arrangements. The international community has called for a global conversation on surrogacy to establish common ethical standards and protect the rights of the most vulnerable.